The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer

March 4, 2011 updated by: Ministry of Health, Malaysia

Strategic Alliance for The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer

More recent studies have shown that the HBV-infected population has a greater risk of development of hepatocellular carcinoma. Nevertheless, there are still a significant number of people chronically infected by HBV who do not develop the complication. Hence, there exist biological markers that could be indicator for the disease-inducing and carcinogenic potential of the virus.

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

1600

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Malaysia
      • Pulau Pinang, Malaysia
        • Not yet recruiting
        • Island Hospital
        • Principal Investigator:
          • Dato' Dr. Robert Ding Phooi Huat
      • Pulau Pinang, Malaysia
        • Recruiting
        • Lam Wah Ee Hospital
        • Principal Investigator:
          • Mr. Kok Thye Yip
      • Pulau Pinang, Malaysia
        • Recruiting
        • Penang Hospital
        • Principal Investigator:
          • Dr. Boon Phoe Ooi
    • Kedah
      • Alor Star, Kedah, Malaysia
        • Recruiting
        • Sultanah Bahiyah Hospital
        • Principal Investigator:
          • Dato' Dr. Muhammad Radzi Abu Hassan
    • Sabah
      • Kota Kinabalu, Sabah, Malaysia
        • Recruiting
        • Queen Elizabeth Hospital
        • Principal Investigator:
          • Dato' Dr. Jayaram Menon
        • Sub-Investigator:
          • Dr. Raman Muthukaruppan
    • Sarawak
      • Kuching, Sarawak, Malaysia
        • Not yet recruiting
        • Hospital Umum Kuching Sarawak
        • Principal Investigator:
          • Mr. Nik Azim Nik Abdullah
    • Selangor
      • Selayang, Selangor, Malaysia
        • Recruiting
        • Selayang Hospital
        • Principal Investigator:
          • Dr. Haniza Omar
        • Sub-Investigator:
          • Dr. Soek Siam Tan
    • Wilayah Persekutuan
      • Kuala Lumpur, Wilayah Persekutuan, Malaysia
        • Not yet recruiting
        • Kuala Lumpur Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Selected hospitals for study

Description

Inclusion Criteria:

  • Patients of at least 21 years old on day of giving consent for study
  • Patients must be able and wiling to give an informed consent
  • Patient with chronic HBV infection
  • Patient with active hepatocellular carcinoma and chronic hepatitis B
  • Healthy subjects

Exclusion Criteria:

  • Patients who have co-infection with HIV or chronic hepatitis C
  • Subjects with other types of cancer

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ministry of Health, Malaysia

Collaborators

GeneNews Sdn Bhd

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2010

Study Completion (ANTICIPATED)

August 1, 2012

Study Registration Dates

First Submitted

March 4, 2011

First Submitted That Met QC Criteria

March 4, 2011

First Posted (ESTIMATE)

March 7, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

March 7, 2011

Last Update Submitted That Met QC Criteria

March 4, 2011

Last Verified

March 1, 2011

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 09-317-3991

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hepatitis B,Chronic

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe